INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders

Clinical trial NCT04455841 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04455841
Sponsor: Incyte Corporation
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anemia Post-essential Thrombocythemia Myelofibrosis Post-polycythemia Vera Myelofibrosis

Start date: 2021-03-19
Primary completion: 2025-04-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.